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ABSTRACT
Introduction Various intracanal medicaments have been
used in cases of chronic apical periodontitis for appropriate
disinfection of the root canal system to eliminate microbes
especially from the inaccessible areas. Calcium hydroxide
is the most common intracanal medicament available in
various forms, but its effectiveness with or without iodoform
using microbial culture is unknown. Therefore, our aim is to
compare the antimicrobial efficacy of Calcipex and Metapex
in endodontic treatment of teeth presenting with chronic
apical periodontitis by assessing the bacterial load reduction.
Method and analysis 60 single rooted teeth of patients
with diagnosis of chronic apical periodontitis will be selected
and the canals debrided chemomechanically. The patients
will be randomised into two groups: Calcipex and Metapex.
The first sample (S1) for bacterial culture will be taken
before placement of intracanal medicament and the second
sample (S2) will be taken after 7 days, before final obturation
from the canal and sent to lab for culture. Colony-forming
unit will be evaluated. Paired t-test will be used to assess
difference between antimicrobial efficacies within the group
of medicaments. Independent sample t-test will be used to
assess antimicrobial efficacies between groups. Level of
significance will be kept at 0.05.
Ethics and dissemination Approval from Aga Khan
University Hospital Ethical review committee is taken.
Findings will be reported according to the Standard Protocol
Items for Randomised Trials guidelines. Research findings
will be disseminated through annual reports, peer-reviewed
journals and conferences.
Trial registration number NCT04336709.

BACKGROUND
Pulpal necrosis may lead to spread of the
infection from the pulp to involve the apex of
the tooth and surrounding bone, which when
asymptomatic with periapical radiolucency
on radiograph, is called chronic apical periodontitis.1 2 In order to eliminate the virulent
bacteria and to overcome the inflammation
in the root apex, endodontic treatment is
the treatment of choice. For the long-term
success of endodontic treatment, complete

Strengths and limitations of this study
►► Our study is first of its kind to determine efficacy be-

tween Calcipex and Metapex using bacterial count.
►► Bacterial culture (colony-forming unit/mL) is one of

the accurate methods in determining presence of
viable bacteria and medicament efficacy.
►► Adequate randomisation, blinding and standardised
protocols will be followed to obtain optimum result
outcome.
►► There may be lost to follow-up, flare-ups or unexpected results.
►► It is a single-centred study, which may be a limitation
and multiple medicaments may be compared in future.
More specific methods like RT-PCR could be used.

debridement and reduction of the bacterial
count using mechanical cleaning and chemical irrigation seems to be necessary.3 Yet
there is no definitive evidence in the literature regarding any of the chemomechanical
debridement methods resulting in complete
elimination of bacteria from the root canal
system.4 5 The complex anatomy of the root
canal system and presence of many in-accessible areas like lateral canals and dentinal
tubules, makes elimination of bacteria from
the infected root canal system challenging.6
The bacteria that survived in the root canal
system might multiply between the appointments or following obturation often reach the
previous pathogenic level, thus ending up in
endodontic failure.7 In order to eliminate the
remaining bacteria, various intracanal medicaments have been used widely. However, there
is lack of consensus over their use and efficacy.8 According to Trope et al9, use of calcium
hydroxide (CH) dressing in periapical infection
reduced the percentage of bacteria upto 90%
to 100%; and thus, significantly improved periapical healing.
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CH is the most commonly used intracanal medicament
that is employed between root canal treatment sessions and
available in different combinations. Calcipex (CalcipexII,
Nishika, Yamaguchi, Japan) is a water-based CH paste but
it is also available with additional substances like iodoform
in oil vehicle (Metapex, Meta Biomed, Korea) which is
claimed to enhance its antimicrobial activity against Enterococcus faecalis.10–12
Multiple studies have been conducted to evaluate the
effect of various types of CH-
based medicaments.13–16
Cwikla et al compared CH mixed with water, CH mixed
with iodine-potassium iodide, and CH mixed with iodoform and silicone oil (Metapex). He concluded that
Metapex is the most effective dentinal tubule disinfectant.17 On the contrary, Estrela et al10 examined the
antimicrobial efficacy of CH with certain vehicles and
concluded that the vehicles did not influence the antimicrobial activity of CH.18 Estrela et al10 in another study
concluded that addition of iodoform does not improve
the antimicrobial efficacy of CH-saline solution. Whether
CH with iodoform is more effective than CH alone against
endodontic pathogens is yet to be established.
There are several methods to evaluate the antimicrobial
effectiveness of intracanal medicaments. PCR is the most
sensitive method for microbial species identification with
less interference but it is costly and not readily available
in dental clinics.19 In order to evaluate the true reduction in microbial load from the infected canals, microbial culture is a predictable and convenient tool. There is
a paucity of literature related to the effectiveness of CH
with or without iodoform using microbial culture.
Thus, this study aims to evaluate the antimicrobial
effectiveness of interappointment intracanal medicament with either CH alone (Calcipex) or CH with iodoform (Metapex) for the treatment of infected root canals
of teeth diagnosed with chronic apical periodontitis by
assessing the bacterial load reduction.
Alternate hypothesis
There is difference in the antimicrobial efficacy of
Calcipex and Metapex in root canals of teeth presenting
with chronic apical periodontitis.
Study objectives
To compare the antimicrobial efficacy of Calcipex and
Metapex in endodontic treatment of teeth presenting
with chronic apical periodontitis
Trial design
Two-arm parallel design, randomised controlled trial.

METHODS AND ANALYSIS
Study setting and duration
Dental Clinics, Aga Khan University Hospital (AKUH),
Karachi. One year after approval by Ethical research
committee of AKUH.
2

Sampling technique
Block randomisation.
Sampling size determination
Sample size was calculated using WHO sample size calculator (Software V.2.0).20 Dutta et al13 showed that the
population mean and SD of teeth treated with CH-based
intracanal medicaments were 50.3±13 colony-
forming
unit (CFU)/mL. Keeping the absolute precision at 0.05
and level of confidence at 95%, the required sample size
turned out to be 26 teeth. The sample is inflated to 30.
As we have two groups, therefore, a total of 60 teeth will
be taken.
Patient and public involvement
Patients will not be involved in the recruitment and
conduct of study. They only will participate as research
participants. They will be informed about the details and
research being conducted and then consent signed. The
consent has all the information mentioned regarding the
study. The results of the study will be emailed to the study
participants at the end of the study.
Sample selection
Inclusion criteria
►► Single rooted human permanent teeth with single
root canal.
►► Clinically diagnosed with chronic apical periodontitis.
►► No history of antibiotics use in last 3 months.
Exclusion criteria
Periodontally compromised teeth with grade III
mobility.
►► Endodontically non-salvageable teeth.
►► Immunocompromised patients/systemic illness.
►► Excessive root resorption.
►► History of allergy to CH or iodoform.
►► Endodontic retreatment cases.
►►

Interventions
Drugs: Intracanal medicaments
1. Calcipex (CalcipexII, Nishika, Yamaguchi, Japan).
Water-based intracanal medicament.
Colour—white.
Formulation—water based.
Duration—7 days.
Form—aste.
Frequency—used once on first day only till canal fills.
based CH paste without radio
Composition—water-
contrast agent (barium sulfate).
Packaging—(1 syringe of Calcipex Plain II (1.8 g), two
needles of Nishika Spin with two needle caps).
Storage requirement—room temperature (1°C–30℃).
2. Metapex (Meta Biomed, Korea)
Oil-based intracanal medicament.
Colour—yellow.
Formulation—oil based
Duration—7 days.
Form: paste.
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Figure 1

Flow diagram. CFU, colony-forming unit.

Frequency: used once on first day only till canal fills.
Composition—premixed oil-based paste composed of
CH with Iodoform and silicon oil.
Packaging—2.2g paste in one syringe. Twenty disposable tips. One ring rotator for direction control of the
tip.
Storage requirement—room temperature (1°C–30℃).
These intracanal medicaments will be placed inside the
root canals at one point in time.
Outcomes
Antimicrobial efficacy (time frame: 7 days).
Antimicrobial efficacy of intracanal medicament as
measuring using CFU/mL via bacterial culture. The
higher CFU/mL suggests more bacterial colonies. We
expect the counts to reduce after using the intracanal
medicament
Participant recruitment
All the patients visiting the dental clinics of Aga Khan
University Hospital will be included who fulfil our inclusion criteria and give consent.
Randomisation, blinding and treatment allocation
The selected subjects will be assigned to one of the two
study groups only known to the researcher who is not
involved in the outcome assessment using block randomisation (figure 1). This would be facilitated by clinical trial
unit (CTU). The block size would be 6.
Motiwala MA, et al. BMJ Open 2021;11:e048947. doi:10.1136/bmjopen-2021-048947

Group A (control group)—Calcipex group (n=30).
Group B (intervention group)—Metapex group
(n=30).
The sample in Eppendorf Tubes will be sent in a zip
lock bag to the microbiology laboratory labelled with
either group A or B. Patient, analyser and the statistician will be blinded about the intervention groups. The
recruitment of patients, collection of samples and placement of intracanal medicament will be performed by a
single investigator. The investigator placing the intracanal
medicament cannot be blinded as the colour of the
two medicaments is different. In case of adverse event,
unblinding will be done
Data collection procedure
Approval from AKUH Ethical review committee was
taken. All patients falling in inclusion criteria will receive
detailed information regarding the study, its advantages,
benefits and risks. Informed consent will be obtained by a
third investigator not involved in data/sample collection.
Ethical review committee approval is obtained. (Ethics
Review Committee (ERC), Ref No: 2020-0304-9040).
Training of the examiner
The participating investigator with at least 4 years of prior
experience will be trained on the development of the
trial, case selection, measurement techniques, sample
3
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collection, data compilation sheets and precise role in
the study.
Procedure
First visit
The tooth diagnosed with chronic apical periodontitis
will be anaesthetised using 2% lidocaine (with 1:100 000
epinephrine) and isolated with the rubber dam. Access
opening will be performed using high and low speed
round bur. Coronal and radicular necrotic pulp will be
extirpated using barbed broaches. The root canal will be
initially prepared by using hand K-files (Endoflex; K-File,
Size 8–20, NiTi) with quarter turn and pull motion. A
23-gauge side vented needle will be used to deliver 1 mL
of sodium hypochlorite for irrigation after each instrument size. The working length will be established with
an apex locator and confirmed by the periapical radiographs. Chemomechanical preparation will be completed
using Protaper Next (Dentsply; Sirona, USA) depending
on both root anatomy and initial diameter of the root
canal. The preparation will be completed in the same
appointment in all cases. After completion of the preparation, the canals will be irrigated with saline and dried
with paper points. A sterile paper point (size 20; EZ Endo,
USA) will be inserted to the confirmed working length of
the canal, and retained in position for 60 s for sampling18
(S1) to soak all the canal contents. Afterwards, the paper
point will be gently removed and placed in an Eppendorf
tube (5 mL) containing Brain Heart Infusion Broth and
sent directly to the microbiology laboratory for microbial
cultivation.
In group A, the canal will be medicated with Calcipex
(CalcipexII, Nishika, Yamaguchi, Japan) which will be
placed by means of lentulo spiral fillers at low speed of
about 5000 rpm21 and packed with a cotton pellet at
the level of canal entrance. Access cavity will be filled
with a temporary resin based filling material, Dia-Temp
(DiaDent Europe BV, Almere, Netherlands) which has the
least microleakage and best sealing ability.22 In group B,
the canal will be medicated with Metapex (Meta Biomed,
Korea) using the same protocol as mentioned above.
Second visit
Patient will be followed up on 7±3 days as the effect of
medicament is at its maximum at seventh day and longer
placement of the medicament may make the tooth brittle
and prone to fracture.23 The tooth will be isolated and
the protocol will be followed the same way as described
before. The temporary filling will be removed and the
paste carried out of the canal by using sterile file and irrigated with normal saline to wash out the medicament.
A postmedication sample will be taken with the help of
sterile paper point in both groups as described previously
(S2). The canals will be then obturated with gutta-percha
and CH sealer (Sealapex, Kerr Dental, USA) by lateral
compaction technique. A definitive restoration will be
placed subsequently.
4

Outcome assessment
It will be done in the microbiology laboratory on the basis
of CFU/mL.
Microbiology lab protocol
The paper point will be taken out from the container and
inserted into the other container filled with enhancement
medium of Brain-Heart Infusion Broth (BHIB), vortexed
for 60 s to remove all bacteria and spread on BHIB. One
mL of BHIB will be added with 1 mL NaCl 0.9%, diluted
and repeated in five series until it reached 105 CFU
bacteria. Each spiral dilute inoculate each dilution in a
sterile petri dish containing blood agar and incubated
anaerobically for 24 hours at 37°C in CO2 incubator. After
24 hours incubation period, the bacterial growth will be
counted and CFU/mL will be calculated.
Data analysis procedure
Data will be analysed using SPSS V.23.0. Mean and SD
of continuous variable will be computed. Frequency
distribution and proportion of categorical variables will
be determined. Paired t-test will be used to assess difference between antimicrobial efficacies within the group of
medicaments. Independent sample t-test will be used to
assess antimicrobial efficacies between groups. Level of
significance will be kept at 0.05.
Data monitoring
Data collection and maintenance would be reviewed
timely by the prinicpal investigator and CTU.
Adverse events
The chances of adverse events in healthy patients are
almost negligible. The product-
related adverse events
would be managed, reported and recorded to ERC within
a specified period of time.
Ethical considerations
Ethical approval is obtained from institutional ERC.
Patients who fulfilled the inclusion criteria will receive
detailed information regarding the study and only those
participants will be recruited who will sign the written
consent form. The study will be conducted according to
the World Medical Association’s Declaration of Helsinki
and the principles of Good Clinical Practice (GCP). Any
subsequent protocol amendments will be submitted to
ERC and regulatory authorities for approval. The trial
will be conducted in compliance with regulations, particularly specifying pharmacovigilance reporting and a copy
of final study report will be submitted to ERC.
Dissemination plan
No publication related to this study has been published
or submitted to any journal. Findings will be reported
according to the Standard Protocol Items for Randomised
Trials guidelines. Research findings will be disseminated
through annual reports. Main study protocol amendments will be reported when findings are disseminated.
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DISCUSSION
There is no risk involved in this study as the study is based
on routine procedure of endodontic treatment. It will be
a benefit for future patients which will help us to decide
which intracanal medicament is more effective to use in
infected canals.
The data will be collected on case report form (CRF)
on first and second visit. The CRF has been developed
by investigator and reviewed by experts of the field. Data
will be stored in a password-protected database. To assure
quality, data will be double checked to avoid discrepancies
and errors. The information provided by the participant
will remain confidential. Nobody except investigators will
have access to it. Participants’ name and identity will not
be disclosed at any time. However, the data may be seen
by ethical review committee, DSMB or any local regulatory body. As per GCP and other guidelines, data will be
retained for 3 years.
Recruitment of patients is started and will be completed
by the end of December 2020.
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